Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis